You are here: Industry Insights > COVID-19

News List

Oxford Immunotec releases the T-SPOT Discovery SARS-CoV-2 kit for COVID-19 research expresspharma
May 21, 2020
This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which in turn could help to bring nations out of their current lockdowns in a faster, safer and more controlled manner.
Inovalon Launches COVID-19 Compass Dashboard contractpharma
May 20, 2020
Provides insights to inform COVID-19 response plans with actionable intelligence pertaining to geographic areas with a high prevalence of COVID-19.
UK's coronavirus testing capacity has been 'inadequate', Committee finds pharmatimes
May 20, 2020
A committee of MPs has concluded that the UK's testing capacity during the novel coronavirus outbreak 'has been inadequate for most of the pandemic so far'.
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics europeanpharmaceuticalreview
May 20, 2020
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.
IFN-α2b therapy shows promise in patients as potential COVID-19 treatment europeanpharmaceuticalreview
May 20, 2020
A group of researchers has found that IFN-α2b therapy reduced blood levels of IL-6 and C-reactive protein, two inflammatory proteins found in COVID-19 patients.
FDA Approves COVID-19 Trial after Successful Emergency Use of Umbilical Stem Cells americanpharmaceuticalreview
May 20, 2020
RESTEM has received approval from the U.S. Food and Drug Administration (FDA) for a 60-patient Phase I/IIa study using umbilical cord mesenchymal stem cells to treat patients with severe cases of COVID-19. The study will be the first of its kind in the US
Roivant Releases Gimsilumab Trial Updates for ARDS Prevention, Treatment for COVID-19 Patients americanpharmaceuticalreview
May 20, 2020
Roivant Sciences announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE trial ...
Akers, Premas Biotech Announce Successful Completion of Vaccine Prototype americanpharmaceuticalreview
May 20, 2020
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
Cipla to explore remdesivir multi-drug combination for Covid-19 pharmaceutical-technology
May 20, 2020
India-based Cipla has plans to explore the use of multi-drug combination, including Gilead Sciences’ investigational antiviral drug remdesivir, for the treatment of Covid-19 coronavirus infection.
ICMRA to discuss alignment on policy approaches and regulatory flexibility during COVID-19 expresspharma
May 20, 2020
The strategic meeting underlined the need and commitment by global regulators to cooperate and align their approaches to clinical trial management, medicine supply issues and pharmacovigilance in light of the medical emergency presented by COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page